Company Overview
- Headquarters
- 2000 Hamilton St Ste 204, Philadelphia PA
- Website
- avax-tech.com
- Phone
- (215) 241-9760
- Employees
- 6
- Founded in
- 1998
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 32541 CompaniesNAICS Code 5417 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 54 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 283 CompaniesSIC Code 28 Companies
Financials & Stats
Revenue
$1B
Who is AVAX Technologies Inc
AVAX Technologies, Inc. is a biotechnology company based in Philadelphia, Pennsylvania. The company employs six people and generates annual revenue of $0.75 million. AVAX Technologies specializes in developing and commercializing its AC Vaccine® technology, a platform designed for the treatment of cancer. This technology focuses on creating personalized cancer vaccines, a complex and unique approach in the field of immuno-oncology. AVAX Technologies distinguishes itself through its advanced stage of development and commercial readiness within the immuno-oncology sector. The company operates a GMP approved facility, one of the few globally capable of producing autologous vaccine products. For more information about AVAX Technologies and its innovative cancer vaccine technology, please visit www.avax-tech.com.
AVAX Technologies Inc Industry Tags
AVAX Technologies Inc Tech Stack
Companies Similar to AVAX Technologies Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to AVAX Technologies Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 5 | Anaheim, CA | 1996 | |
| 1M | 5 | Grand Rapids, MI | 2010 | |
| 1M | 14 | San Diego, CA | 2008 | |
| 1M | 8 | San Carlos, CA | 2013 | |
| 1M | 12 | Yonkers, NY | 2008 |